Publication Name	World Journal of Gastroenterology
Manuscript ID	42512
Country	United States

Received	2018-09-28 02:12
Peer-Review Started	2018-09-28 08:39
To Make the First Decision	2018-10-24 02:06
Return for Revision	2018-10-26 07:30
Revised	2018-11-07 02:56
Second Decision	2018-11-16 07:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2018-11-16 18:41
Articles in Press	2018-11-16 18:41
Publication Fee Transferred
Edit the Manuscript by Language Editor	2018-11-28 19:16
Typeset the Manuscript	2018-12-26 02:45
Publish the Manuscript Online	2018-12-27 08:56

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Checkpoint inhibitors: What gastroenterologists need to know
Manuscript Source	Unsolicited Manuscript
All Author List	Monjur Ahmed
ORCID	Author(s) ORCID Number Monjur Ahmed http://orcid.org/0000-0003-0515-9224
Funding Agency and Grant Number
Corresponding Author	Monjur Ahmed, FACG, FACP, FASGE, MD, MRCP, Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Thomas Jefferson University, 132 South 10th Street, Suite 468, Main Building, Philadelphia, PA 19107, United States. monjur.ahmed@jefferson.edu
Key Words	Checkpoint inhibitors; Immunotherapy; Gastrointestinal management; Hepatic and pancreatic side effects
Core Tip	Checkpoint inhibitors are a kind of immuno­therapy used in the treatment of various malignancies. Nevertheless, they carry the risk of causing different immune-related side effects. Physicians should be vigilant in recognizing and appropriately managing these side effects for a better outcome.
Publish Date	2018-12-27 08:56
Citation	Ahmed M. Checkpoint inhibitors: what gastroenterologists need to know. World J Gastroenterol 2018; 24(48): 5433-5438
URL	https://www.wjgnet.com/1007-9327/full/v24/i48/5433.htm
DOI	https://dx.doi.org/10.3748/wjg.v24.i48.5433

Full Article (PDF)	WJG-24-5433.pdf
Full Article (Word)	WJG-24-5433.docx
Manuscript File	42512-Review.docx
Answering Reviewers	42512-Answering reviewers.pdf
Audio Core Tip	42512-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	42512-Conflict-of-interest statement.pdf
Copyright License Agreement	42512-Copyright license agreement.pdf
Peer-review Report	42512-Peer-review(s).pdf
Scientific Misconduct Check	42512-Scientific misconduct check.pdf
Scientific Editor Work List	42512-Scientific editor work list.pdf